Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4851
SeaStar Medical
ICU
$10M
| $2.49K | ﹤0.01% |
633
+629
| +15,725% | +$2.26K |
2026 Q2
1 quarter
|
|
4852
Innovator Premium Income 15 Buffer ETF October
LOCT
$11.2M
| $2.48K | ﹤0.01% |
104
| – | – |
2026 Q2
1 quarter
|
|
4853
Boqii Holding Ltd
BQ
$3.11M
| $2.47K | ﹤0.01% |
3,121
| – | – |
2023 Q4
11 quarters
|
|
4854
Incannex Healthcare Limited Common Stock
IXHL
$28.1M
| $2.43K | ﹤0.01% |
750
| – | – |
2024 Q1
10 quarters
|
|
4855
Tema Space Innovators ETF
NASA
$4.07B
| $2.3K | ﹤0.01% |
96
-500
| -84% | -$12.2K |
2026 Q2
1 quarter
|
|
4856
AIB Data Centers
AIB
$54.6M
| $2.28K | ﹤0.01% |
1,711
-966
| -36% | -$1.55K |
2026 Q2
1 quarter
|
|
4857
Alpha Pro Tech
APT
$55.3M
| $2.26K | ﹤0.01% |
442
+16
| +4% | +$83 |
2024 Q3
8 quarters
|
|
4858
Polestar Automotive Holding ADS Class C-1
PSNYW
$486M
| $2.26K | ﹤0.01% |
520
| – | – |
2022 Q2
17 quarters
|
|
4859
Energys Group
ENGS
$212M
| $2.16K | ﹤0.01% |
709
| – | – |
2025 Q4
3 quarters
|
|
4860
DELISTED
Leslie's
LESL
| $2.14K | ﹤0.01% |
+13,386
| New | +$23.5K |
2026 Q3
0 quarters
|
|
4861
Insight Molecular Diagnostics
IMDX
$81.5M
| $2.1K | ﹤0.01% |
+584
| New | +$2.58K |
2026 Q3
0 quarters
|
|
4862
AllianzIM U.S. Equity Buffer10 Oct ETF
OCTT
$117M
| $2.08K | ﹤0.01% |
43
| – | – |
2025 Q4
3 quarters
|
|
4863
Coca-Cola Femsa
KOF
$24B
| $2.05K | ﹤0.01% |
+19
| New | +$2.07K |
2026 Q3
0 quarters
|
|
4864
Innovator Premium Income 15 Buffer ETF - July
LJUL
$8.9M
| $2.03K | ﹤0.01% |
85
+53
| +166% | +$1.27K |
2026 Q1
2 quarters
|
|
4865
Brilliant Earth
BRLT
$24.5M
| $2.02K | ﹤0.01% |
1,516
-281
| -16% | -$355 |
2021 Q4
19 quarters
|
|
4866
Innovator US Equity Buffer ETF March
BMAR
$197M
| $2.01K | ﹤0.01% |
34
-79
| -70% | -$4.62K |
2026 Q2
1 quarter
|
|
4867
Innovator US Equity Power Buffer ETF November
PNOV
$808M
| $2.01K | ﹤0.01% |
44
-92
| -68% | -$4.15K |
2025 Q1
6 quarters
|
|
4868
Innovator Equity Defined Protection ETF - 1 Yr November
ZNOV
$106M
| $1.98K | ﹤0.01% |
71
-1,435
| -95% | -$39.8K |
2026 Q1
2 quarters
|
|
4869
60 Degrees Pharmaceuticals
SXTP
$2.09M
| $1.96K | ﹤0.01% |
1,475
+423
| +40% | +$520 |
2025 Q4
3 quarters
|
|
4870
iShares MSCI South Africa ETF
EZA
$476M
| $1.92K | ﹤0.01% |
30
| – | – |
2022 Q1
18 quarters
|
|
4871
Innovator Premium Income 15 Buffer ETF April
LAPR
$10.6M
| $1.89K | ﹤0.01% |
75
-4
| -5% | -$101 |
2025 Q2
5 quarters
|
|
4872
Rafael Holdings
RFL
$54.3M
| $1.88K | ﹤0.01% |
1,424
+1,175
| +472% | +$2.58K |
2026 Q2
1 quarter
|
|
4873
iShares MSCI United Kingdom ETF
EWU
$3.69B
| $1.86K | ﹤0.01% |
40
| – | – |
2013 Q2
53 quarters
|
|
4874
ATIF Holdings
AUC
$67.7M
| $1.82K | ﹤0.01% |
+200
| New | +$1.5K |
2026 Q3
0 quarters
|
|
4875
Atara Biotherapeutics
ATRA
$79M
| $1.82K | ﹤0.01% |
214
-90
| -30% | -$815 |
2026 Q2
1 quarter
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.